Annual Current Assets
$485.06 M
-$19.20 M-3.81%
December 31, 2024
Summary
- As of February 22, 2025, AXSM annual total current assets is $485.06 million, with the most recent change of -$19.20 million (-3.81%) on December 31, 2024.
- During the last 3 years, AXSM annual current assets has risen by +$398.55 million (+460.65%).
- AXSM annual current assets is now -3.81% below its all-time high of $504.26 million, reached on December 31, 2023.
Performance
AXSM Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
N/A
December 31, 2024
Summary
- AXSM quarterly total current assets is not available.
Performance
AXSM Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
AXSM Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.8% | - |
| 3 y3 years | +460.6% | - |
| 5 y5 years | +120.1% | - |
AXSM Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.8% | +460.6% | ||
| 5 y | 5-year | -3.8% | +460.6% | ||
| alltime | all time | -3.8% | >+9999.0% |
Axsome Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $83.43 M(-0.6%) | - |
| Sep 2024 | - | $479.11 M(+3.5%) |
| Jun 2024 | - | $463.03 M(+0.6%) |
| Mar 2024 | - | $460.49 M(-8.7%) |
| Dec 2023 | $83.97 M(-2.2%) | $504.26 M(-1.5%) |
| Sep 2023 | - | $511.76 M(-1.5%) |
| Jun 2023 | - | $519.69 M(+70.7%) |
| Mar 2023 | - | $304.45 M(+23.9%) |
| Dec 2022 | $85.83 M(+6675.1%) | $245.64 M(-2.7%) |
| Sep 2022 | - | $252.38 M(+142.7%) |
| Jun 2022 | - | $103.98 M(+19.7%) |
| Mar 2022 | - | $86.83 M(+0.4%) |
| Dec 2021 | $1.27 M(-39.9%) | $86.52 M(-24.8%) |
| Sep 2021 | - | $115.02 M(-18.8%) |
| Jun 2021 | - | $141.65 M(-14.2%) |
| Mar 2021 | - | $165.04 M(-10.3%) |
| Dec 2020 | $2.11 M(+1137.2%) | $184.02 M(-9.5%) |
| Sep 2020 | - | $203.27 M(+6.5%) |
| Jun 2020 | - | $190.82 M(-3.4%) |
| Mar 2020 | - | $197.62 M(-10.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $170.50 K(+3.8%) | $220.38 M(+398.2%) |
| Sep 2019 | - | $44.24 M(-18.9%) |
| Jun 2019 | - | $54.57 M(+24.7%) |
| Mar 2019 | - | $43.76 M(+187.6%) |
| Dec 2018 | $164.20 K(-35.9%) | $15.22 M(-4.6%) |
| Sep 2018 | - | $15.94 M(-26.0%) |
| Jun 2018 | - | $21.54 M(-22.4%) |
| Mar 2018 | - | $27.75 M(-21.4%) |
| Dec 2017 | $256.00 K(+19.9%) | $35.30 M(+8.9%) |
| Sep 2017 | - | $32.42 M(-16.5%) |
| Jun 2017 | - | $38.84 M(-15.9%) |
| Mar 2017 | - | $46.20 M(+21.6%) |
| Dec 2016 | $213.60 K(+393.3%) | $38.00 M(+9.3%) |
| Sep 2016 | - | $34.75 M(-12.9%) |
| Jun 2016 | - | $39.92 M(-11.4%) |
| Mar 2016 | - | $45.07 M(-8.1%) |
| Dec 2015 | $43.30 K(+1.6%) | $49.03 M(+887.5%) |
| Sep 2015 | - | $4.97 M(-25.5%) |
| Jun 2015 | - | $6.67 M(+143.0%) |
| Dec 2014 | $42.60 K(>+9900.0%) | $2.74 M |
| Dec 2013 | $0.00 | - |
FAQ
- What is Axsome Therapeutics annual total current assets?
- What is the all time high annual current assets for Axsome Therapeutics?
- What is Axsome Therapeutics annual current assets year-on-year change?
- What is the all time high quarterly current assets for Axsome Therapeutics?
What is Axsome Therapeutics annual total current assets?
The current annual current assets of AXSM is $485.06 M
What is the all time high annual current assets for Axsome Therapeutics?
Axsome Therapeutics all-time high annual total current assets is $504.26 M
What is Axsome Therapeutics annual current assets year-on-year change?
Over the past year, AXSM annual total current assets has changed by -$19.20 M (-3.81%)
What is the all time high quarterly current assets for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly total current assets is $519.69 M